Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?
Keyword(s):
Keyword(s):
2014 ◽
Vol 90
(1)
◽
pp. S547
Keyword(s):
2013 ◽
Vol 109
(2)
◽
pp. 262-268
◽
Keyword(s):
2020 ◽
Vol 9
(4)
◽
pp. 298-302
2007 ◽
Vol 5
(4)
◽
pp. 334-335
Keyword(s):
2009 ◽
Vol 75
(2)
◽
pp. 378-384
◽
Keyword(s):
2015 ◽
Vol 93
(1)
◽
pp. 37-46
◽